| Miss Katherine M Becher, FNP | |
|
250 Hospital Pl, Soldotna, AK 99669-6999 | |
| (907) 714-4444 | |
| Not Available |
| Full Name | Miss Katherine M Becher |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 30 Years |
| Location | 250 Hospital Pl, Soldotna, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003972043 | NPI | - | NPPES |
| 1022748 | Medicaid | AK | |
| 361 | Other | AK | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 361 (Alaska) | Secondary |
| 363L00000X | Nurse Practitioner | NURU361 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Peninsula General Hospital Inc | 4587552575 | 85 |
News Archive
EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the Phase III STARTa trial of its investigational product L-BLP25 (formerly referred to as Stimuvax) in patients with unresectable, locally advanced stage IIIA or IIIB non-small cell lung cancer (NSCLC) did not meet its primary endpoint to demonstrate a statistically significant improvement in overall survival (OS).
In his monthly column "Pulling It Together," Kaiser Family Foundation President and CEO Drew Altman discusses a recent conversation between The Daily Show host Jon Stewart and U2 lead singer Bono that "captures the tension between the opportunity for new optimism and the continuing need for realism about the AIDS epidemic."
DNA microarrays are one of the most powerful tools in molecular biology today. The devices, which can be used to probe biological samples and detect particular genes or genetic sequences, are employed in everything from forensic analysis to disease detection to drug development.
Chemists at Ruhr-Universität Bochum have developed a new method of observing the chemical reactions of individual silver nanoparticles, which only measure a thousandth of the thickness of a human hair, in real time.
› Verified 8 days ago
| Entity Name | Central Peninsula General Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528062429 PECOS PAC ID: 4587552575 Enrollment ID: O20040310000598 |
News Archive
EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the Phase III STARTa trial of its investigational product L-BLP25 (formerly referred to as Stimuvax) in patients with unresectable, locally advanced stage IIIA or IIIB non-small cell lung cancer (NSCLC) did not meet its primary endpoint to demonstrate a statistically significant improvement in overall survival (OS).
In his monthly column "Pulling It Together," Kaiser Family Foundation President and CEO Drew Altman discusses a recent conversation between The Daily Show host Jon Stewart and U2 lead singer Bono that "captures the tension between the opportunity for new optimism and the continuing need for realism about the AIDS epidemic."
DNA microarrays are one of the most powerful tools in molecular biology today. The devices, which can be used to probe biological samples and detect particular genes or genetic sequences, are employed in everything from forensic analysis to disease detection to drug development.
Chemists at Ruhr-Universität Bochum have developed a new method of observing the chemical reactions of individual silver nanoparticles, which only measure a thousandth of the thickness of a human hair, in real time.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Katherine M Becher, FNP 250 Hospital Pl, Soldotna, AK 99669-6999 Ph: (907) 714-4444 | Miss Katherine M Becher, FNP 250 Hospital Pl, Soldotna, AK 99669-6999 Ph: (907) 714-4444 |
News Archive
EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the Phase III STARTa trial of its investigational product L-BLP25 (formerly referred to as Stimuvax) in patients with unresectable, locally advanced stage IIIA or IIIB non-small cell lung cancer (NSCLC) did not meet its primary endpoint to demonstrate a statistically significant improvement in overall survival (OS).
In his monthly column "Pulling It Together," Kaiser Family Foundation President and CEO Drew Altman discusses a recent conversation between The Daily Show host Jon Stewart and U2 lead singer Bono that "captures the tension between the opportunity for new optimism and the continuing need for realism about the AIDS epidemic."
DNA microarrays are one of the most powerful tools in molecular biology today. The devices, which can be used to probe biological samples and detect particular genes or genetic sequences, are employed in everything from forensic analysis to disease detection to drug development.
Chemists at Ruhr-Universität Bochum have developed a new method of observing the chemical reactions of individual silver nanoparticles, which only measure a thousandth of the thickness of a human hair, in real time.
› Verified 8 days ago